|
1
|
Kaur J: A comprehensive review on
metabolic syndrome. Cardiol Res Pract. 2014:9431622014.PubMed/NCBI
|
|
2
|
Al-Daghri NM, Al-Attas OS, Alokail MS,
Alkharfy KM, Charalampidis P, Livadas S, Kollias A, Sabico SL and
Chrousos GP: Visceral adiposity index is highly associated with
adiponectin values and glycaemic disturbances. Eur J Clin Invest.
43:183–189. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Simmons RK, Alberti KG, Gale EA, Colagiuri
S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich
Mirchov I, et al: The metabolic syndrome: Useful concept or
clinical tool? Report of a WHO Expert Consultation. Diabetologia.
53:600–605. 2010. View Article : Google Scholar
|
|
4
|
O'Brien PE, MacDonald L, Anderson M,
Brennan L and Brown WA: Long-term outcomes after bariatric surgery:
Fifteen-year follow-up of adjustable gastric banding and a
systematic review of the bariatric surgical literature. Ann Surg.
257:87–94. 2013. View Article : Google Scholar
|
|
5
|
Inzucchi SE, Bergenstal RM, Buse JB,
Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R and
Matthews DR: Management of hyperglycaemia in type 2 diabetes: A
patient-centered approach. Position statement of the American
Diabetes Association (ADA) and the European Association for the
Study of Diabetes (EASD). Diabetologia. 55:1577–1596. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alexandre KB, Smit AM, Gray IP and
Crowther NJ: Metformin inhibits intracellular lipid accumulation in
the murine pre-adipocyte cell line, 3T3-L1. Diabetes Obes Metab.
10:688–690. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang J, Fu M, Ciociola E, Chandalia M and
Abate N: Role of ENPP1 on adipocyte maturation. PLoS One.
2:e8822007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fernández-Hernando C, Ramírez CM, Goedeke
L and Suárez Y: MicroRNAs in metabolic disease. Arterioscler Thromb
Vasc Biol. 33:178–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao Y, Xue J, Li X, Jia Y and Hu J:
Metformin regulates osteoblast and adipocyte differentiation of rat
mesenchymal stem cells. J Pharm Pharmacol. 60:1695–1700. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carrer M, Liu N, Grueter CE, Williams AH,
Frisard MI, Hulver MW, Bassel-Duby R and Olson EN: Control of
mitochondrial metabolism and systemic energy homeostasis by
microRNAs 378 and 378*. Proc Natl Acad Sci USA. 109:15330–15335.
2012. View Article : Google Scholar
|
|
11
|
Wilson B, Liotta LA and Petricoiniii E:
Dynamic protein pathway activation mapping of adipose-derived stem
cell differentiation implicates novel regulators of adipocyte
differentiation. Mol Cell Proteomics. 12:2522–2535. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Berg AH, Combs TP and Scherer PE:
ACRP30/adiponectin: An adipokine regulating glucose and lipid
metabolism. Trends Endocrinol Metab. 13:84–89. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kato K, Gong J, Iwama H, Kitanaka A, Tani
J, Miyoshi H, Nomura K, Mimura S, Kobayashi M, Aritomo Y, et al:
The anti-diabetic drug metformin inhibits gastric cancer cell
proliferation in vitro and in vivo. Mol Cancer Ther. 11:549–560.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fujita K, Iwama H, Sakamoto T, Okura R,
Kobayashi K, Takano J, Katsura A, Tatsuta M, Maeda E, Mimura S, et
al: Galectin-9 suppresses the growth of hepatocellular carcinoma
via apoptosis in vitro and in vivo. Int J Oncol. 46:2419–2430.
2015.PubMed/NCBI
|
|
15
|
Masaki T, Okada M, Tokuda M, Shiratori Y,
Hatase O, Shirai M, Nishioka M and Omata M: Reduced C-terminal Src
kinase (Csk) activities in hepatocellular carcinoma. Hepatology.
29:379–384. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miyoshi H, Kato K, Iwama H, Maeda E,
Sakamoto T, Fujita K, Toyota Y, Tani J, Nomura T, Mimura S, et al:
Effect of the anti-diabetic drug metformin in hepatocellular
carcinoma in vitro and in vivo. Int J Oncol. 45:322–332.
2014.PubMed/NCBI
|
|
17
|
Kobayashi M, Kato K, Iwama H, Fujihara S,
Nishiyama N, Mimura S, Toyota Y, Nomura T, Nomura K, Tani J, et al:
Antitumor effect of metformin in esophageal cancer: In vitro study.
Int J Oncol. 42:517–524. 2013.
|
|
18
|
Fujimori T, Kato K, Fujihara S, Iwama H,
Yamashita T, Kobayashi K, Kamada H, Morishita A, Kobara H, Mori H,
et al: Antitumor effect of metformin on cholangiocarcinoma: In
vitro and in vivo studies. Oncol Rep. 34:2987–2996. 2015.PubMed/NCBI
|
|
19
|
Fujihara S, Kato K, Morishita A, Iwama H,
Nishioka T, Chiyo T, Nishiyama N, Miyoshi H, Kobayashi M, Kobara H,
et al: Antidiabetic drug metformin inhibits esophageal
adenocarcinoma cell proliferation in vitro and in vivo. Int J
Oncol. 46:2172–2180. 2015.PubMed/NCBI
|
|
20
|
Kato K, Iwama H, Yamashita T, Kobayashi K,
Fujihara S, Fujimori T, Kamada H, Kobara H and Masaki T: The
anti-diabetic drug metformin inhibits pancreatic cancer cell
proliferation in vitro and in vivo: Study of the microRNAs
associated with the antitumor effect of metformin. Oncol Rep.
35:1582–1592. 2016.
|
|
21
|
Fujita K, Kobara H, Mori H, Fujihara S,
Chiyo T, Matsunaga T, Nishiyama N, Ayaki M, Yachida T, Morishita A,
et al: Differences in miRNA expression profiles between GIST and
leiomyoma in human samples acquired by submucosal tunneling biopsy.
Endosc Int Open. 3:E665–E671. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nigro E, Scudiero O, Monaco ML, Palmieri
A, Mazzarella G, Costagliola C, Bianco A and Daniele A: New insight
into adiponectin role in obesity and obesity-related diseases.
BioMed Res Int. 2014:6589132014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu Z, Rosen ED, Brun R, Hauser S, Adelmant
G, Troy AE, McKeon C, Darlington GJ and Spiegelman BM:
Cross-regulation of C/EBP alpha and PPAR gamma controls the
transcriptional pathway of adipogenesis and insulin sensitivity.
Mol Cell. 3:151–158. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakagami H: The mechanism of white and
brown adipocyte differentiation. Diabetes Metab J. 37:85–90. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Son YH, Ka S, Kim AY and Kim JB:
Regulation of adipocyte differentiation via MicroRNAs. Endocrinol
Metab (Seoul). 29:122–135. 2014. View Article : Google Scholar
|
|
27
|
Callegari E, Elamin BK, Sabbioni S,
Gramantieri L and Negrini M: Role of microRNAs in hepatocellular
carcinoma: A clinical perspective. Onco Targets Ther. 6:1167–1178.
2013.PubMed/NCBI
|
|
28
|
Kerr TA, Korenblat KM and Davidson NO:
MicroRNAs and liver disease. Transl Res. 157:241–252. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gerin I, Bommer GT, McCoin CS, Sousa KM,
Krishnan V and MacDougald OA: Roles for miRNA-378/378* in adipocyte
gene expression and lipogenesis. Am J Physiol Endocrinol Metab.
299:E198–E206. 2010.PubMed/NCBI
|
|
30
|
Shin KK, Kim YS, Kim JY, Bae YC and Jung
JS: miR-137 controls proliferation and differentiation of human
adipose tissue stromal cells. Cell Physiol Biochem. 33:758–768.
2014. View Article : Google Scholar : PubMed/NCBI
|
